FocusCell Biology

A ligand for ALK

See allHide authors and affiliations

Science Signaling  20 Jan 2015:
Vol. 8, Issue 360, pp. fs2
DOI: 10.1126/scisignal.aaa5566


The receptor tyrosine kinase ALK (anaplastic lymphoma kinase), as its name suggests, is aberrantly activated, mutated, or abundant in multiple cancers. Although widely studied in the context of cancer, the ligand that normally binds to and activates ALK in vertebrates has remained elusive. In this issue of Science Signaling, Murray and colleagues identify heparin as an ALK ligand.

View Full Text

Stay Connected to Science Signaling